Consolidated Statements of Changes in Mezzanine Equity and Stockholders’ Equity - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022			109,696,178
Beginning balance at Dec. 31, 2022	$ 63,953		$ 110	$ 757,951	$ (693,307)	$ (801)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock as dividend on convertible preferred stock (in shares)			30,640
Stock issued during period, value, stock options exercised (in shares)			18,037
Issuance of common stock pursuant to exercise of stock options	143			143
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			1,155,826
Issuance of common stock pursuant to settlement of restricted stock units	0		$ 1	(1)
Common stock surrendered for employees' tax liability upon settlement or restricted stock units (in shares)			(373,797)
Common stock surrendered for employees' tax liability upon settlement of restricted stock units	(3,162)		$ (1)	(3,161)
Stock-based compensation	20,162			20,162
Other comprehensive income	366					366
Net loss	(60,798)				(60,798)
Ending balance (in shares) at Mar. 31, 2023			110,526,884
Ending balance at Mar. 31, 2023	$ 20,664		$ 110	775,094	(754,105)	(435)
Beginning balance (in shares) at Dec. 31, 2022		40,000
Beginning balance at Dec. 31, 2022		$ 39,914
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net		$ 11
Ending balance (in shares) at Mar. 31, 2023		40,000
Ending balance at Mar. 31, 2023		$ 39,925
Beginning balance (in shares) at Dec. 31, 2023	117,372,171		117,372,171
Beginning balance at Dec. 31, 2023	$ 2,748		$ 117	826,146	(823,333)	(182)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock as dividend on convertible preferred stock (in shares)	30,640		30,640
Stock issued during period, value, stock options exercised (in shares)	15,333		15,333
Issuance of common stock pursuant to exercise of stock options	$ 94			94
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			2,099,383
Issuance of common stock pursuant to settlement of restricted stock units	0		$ 2	(2)
Common stock surrendered for employees' tax liability upon settlement or restricted stock units (in shares)			(77,286)
Common stock surrendered for employees' tax liability upon settlement of restricted stock units	(529)			(529)
Stock-based compensation	18,674			18,674
Other comprehensive income	37					37
Net loss	$ (66,774)				(66,774)
Ending balance (in shares) at Mar. 31, 2024	119,440,241		119,440,241
Ending balance at Mar. 31, 2024	$ (45,750)		$ 119	$ 844,383	$ (890,107)	$ (145)
Beginning balance (in shares) at Dec. 31, 2023	40,000	40,000
Beginning balance at Dec. 31, 2023	$ 39,959	$ 39,959
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net		$ 11
Ending balance (in shares) at Mar. 31, 2024	40,000	40,000
Ending balance at Mar. 31, 2024	$ 39,970	$ 39,970